Insider · CIK 0001632111

O'Brien James Michael

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001632111

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-23	CGTXCOGNITION THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2021-10-13	CGTXCOGNITION THERAPEUTICS INCP Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$12.00	+$60K	5,000
2021-10-07	CGTXCOGNITION THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+54.5K sh	—	—	54,457
2019-01-03	ENZO BIOCHEM INCStock Option (to acquire common stock)A Award	EVP of Finance	AAward	+52K sh	—	—	33,666
2018-07-31	ENZO BIOCHEM INCStock Option (to acquire common stock)A Award	EVP of Finance	AAward	+35K sh	—	—	23,666
2017-10-27	ENZO BIOCHEM INCM Exercise/Conversion	EVP of Finance	MExercise/Conversion	+6,699 sh	$2.75	+$18.4K	34,886
2017-10-27	ENZO BIOCHEM INCM Exercise/Conversion	EVP of Finance	MExercise/Conversion	+7,500 sh	$3.40	+$25.5K	42,386
2017-10-27	ENZO BIOCHEM INCM Exercise/Conversion	EVP of Finance	MExercise/Conversion	+8,667 sh	$4.35	+$37.7K	51,053
2017-10-27	ENZO BIOCHEM INCS Sale	EVP of Finance	SSale	−6,699 sh	$10.28	−$68.9K	44,354
2017-10-27	ENZO BIOCHEM INCS Sale	EVP of Finance	SSale	−7,500 sh	$10.28	−$77.1K	36,854
2017-10-27	ENZO BIOCHEM INCS Sale	EVP of Finance	SSale	−8,667 sh	$10.28	−$89.1K	28,187
2017-10-27	ENZO BIOCHEM INCStock Option (to acquire common stock)M Exercise/Conversion	EVP of Finance	MExercise/Conversion	−6,699 sh	$2.75	−$18.4K	68,501
2017-10-27	ENZO BIOCHEM INCStock Option (to acquire common stock)M Exercise/Conversion	EVP of Finance	MExercise/Conversion	−7,500 sh	$3.40	−$25.5K	61,001
2017-10-27	ENZO BIOCHEM INCStock Option (to acquire common stock)M Exercise/Conversion	EVP of Finance	MExercise/Conversion	−8,667 sh	$4.35	−$37.7K	52,334
2017-06-13	ENZO BIOCHEM INCS Sale	EVP of Finance	SSale	−13.3K sh	$10.13	−$135K	13,300
2017-06-13	ENZO BIOCHEM INCS Sale	EVP of Finance	SSale	−2,500 sh	$10.13	−$25.3K	15,800
2017-06-13	ENZO BIOCHEM INCStock Option (to acquire common stock)M Exercise/Conversion	EVP of Finance	MExercise/Conversion	−13.3K sh	$2.75	−$36.6K	77,700
2017-06-13	ENZO BIOCHEM INCStock Option (to acquire common stock)M Exercise/Conversion	EVP of Finance	MExercise/Conversion	−2,500 sh	$3.40	−$8,500	75,200
2017-01-05	ENZO BIOCHEM INCStock Option (to acquire common stock)A Award	EVP of Finance	AAward	+30K sh	—	—	91,000
2016-03-14	ENZO BIOCHEM INCStock Option (to acquire common stock)A Award	EVP of Finance	AAward	+26K sh	—	—	61,000

Recent filings

Accepted (ET)
Mar 254
O'Brien James Michael0001062993-22-008679
SEC(opens sec.gov)
Oct 144
O'Brien James Michael0001104659-21-126361
SEC(opens sec.gov)
Oct 124
O'Brien James Michael0001882178-21-000027
SEC(opens sec.gov)
Jan 44
O'Brien James Michael0000930413-19-000024
SEC(opens sec.gov)
Aug 24
O'Brien James Michael0000930413-18-002502
SEC(opens sec.gov)
Oct 304
O'Brien James Michael0000930413-17-003670
SEC(opens sec.gov)
Jun 154
ENZO BIOCHEM INC0001144204-17-032755
SEC(opens sec.gov)
Jan 104
ENZO BIOCHEM INC0000914760-17-000008
SEC(opens sec.gov)
Mar 164
ENZO BIOCHEM INC0000914760-16-000387
SEC(opens sec.gov)

Companies

Address

C/O ENZO BIOCHEM INC. 527 MADISON AVE.

NEW YORK, NY, 10022